Skip to content
TrialScanner

NCT03065192

Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease

Phase 1CompletedNBIXLeadVYGRCollaborator

Registry record

Lead sponsor
Neurocrine Biosciences
Conditions
Idiopathic Parkinson's Disease; Parkinson's Disease; Basal Ganglia Disease; Brain Diseases; Central Nervous System Diseases
Primary completion
Aug 10, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03065192 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03065192: Safety and Efficacy Study of... | TrialScanner